Investors and media

  • 2010

    8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

    Read More >

  • Meet us

    The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

    Read More >

Investors and media

Zealand Pharma has financed its operations since inception through:

  • private placements of equity securities and loans
  • milestone
  • extension and up-front license payments received under its collaboration and licensing agreements
  • funding for research from public sources and from its partners and licensees
  • interest income.

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.



Related links